HK1137186A1 - Consensus peptide - Google Patents
Consensus peptideInfo
- Publication number
- HK1137186A1 HK1137186A1 HK10104769.9A HK10104769A HK1137186A1 HK 1137186 A1 HK1137186 A1 HK 1137186A1 HK 10104769 A HK10104769 A HK 10104769A HK 1137186 A1 HK1137186 A1 HK 1137186A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- consensus peptide
- biomineralization
- mineralization
- stimulation
- induction
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000033558 biomineral tissue development Effects 0.000 abstract 4
- 230000006698 induction Effects 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 230000000638 stimulation Effects 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyamides (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87614906P | 2006-12-21 | 2006-12-21 | |
PCT/IB2007/004068 WO2008078167A2 (en) | 2006-12-21 | 2007-12-21 | Consensus peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1137186A1 true HK1137186A1 (en) | 2010-07-23 |
Family
ID=39387381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10104769.9A HK1137186A1 (en) | 2006-12-21 | 2010-05-14 | Consensus peptide |
Country Status (13)
Country | Link |
---|---|
US (1) | US8367602B2 (xx) |
EP (1) | EP2118136B1 (xx) |
JP (1) | JP5253412B2 (xx) |
KR (2) | KR101493437B1 (xx) |
AT (1) | ATE475670T1 (xx) |
AU (1) | AU2007337797B2 (xx) |
CA (1) | CA2673382C (xx) |
DE (1) | DE602007008147D1 (xx) |
DK (1) | DK2118136T3 (xx) |
ES (1) | ES2349889T3 (xx) |
HK (1) | HK1137186A1 (xx) |
PL (1) | PL2118136T3 (xx) |
WO (1) | WO2008078167A2 (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011111832A1 (ja) * | 2010-03-11 | 2011-09-15 | 独立行政法人理化学研究所 | ポリペプチド配列の選択方法、並びに金属酸化物または含珪素化合物結合ペプチドおよびその利用 |
SE537635C2 (sv) | 2012-09-18 | 2015-08-25 | Corticalis As | Metod för att producera en alginatbelagd titandioxidscaffold, denna titandioxidscaffold samt medicinskt implantatinnefattande scaffolden |
EP4125993A4 (en) * | 2020-03-26 | 2024-04-24 | Bone Sci. Bio Ltd. | PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL108947A0 (en) * | 1993-03-12 | 1994-06-24 | Osteopharm Ltd | Bone stimulating factor |
US5786327A (en) | 1993-03-12 | 1998-07-28 | Gensci Regeneration Sciences Inc. | Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same |
US7132015B2 (en) * | 2002-02-20 | 2006-11-07 | University Of Southern California | Materials for dental and biomedical application |
EP1830863A2 (en) * | 2004-12-10 | 2007-09-12 | Straumann Holding AG | Protein formulation |
WO2006126595A1 (ja) * | 2005-05-27 | 2006-11-30 | Japan Science And Technology Agency | 機能性材料の三次元構造体 |
-
2007
- 2007-12-21 DE DE602007008147T patent/DE602007008147D1/de active Active
- 2007-12-21 PL PL07866581T patent/PL2118136T3/pl unknown
- 2007-12-21 KR KR1020097015360A patent/KR101493437B1/ko active IP Right Grant
- 2007-12-21 KR KR1020147036230A patent/KR20150014999A/ko not_active Application Discontinuation
- 2007-12-21 WO PCT/IB2007/004068 patent/WO2008078167A2/en active Application Filing
- 2007-12-21 CA CA2673382A patent/CA2673382C/en not_active Expired - Fee Related
- 2007-12-21 US US12/520,651 patent/US8367602B2/en active Active
- 2007-12-21 JP JP2009542264A patent/JP5253412B2/ja active Active
- 2007-12-21 AU AU2007337797A patent/AU2007337797B2/en not_active Ceased
- 2007-12-21 EP EP07866581A patent/EP2118136B1/en active Active
- 2007-12-21 AT AT07866581T patent/ATE475670T1/de not_active IP Right Cessation
- 2007-12-21 DK DK07866581.7T patent/DK2118136T3/da active
- 2007-12-21 ES ES07866581T patent/ES2349889T3/es active Active
-
2010
- 2010-05-14 HK HK10104769.9A patent/HK1137186A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2673382A1 (en) | 2008-07-03 |
DE602007008147D1 (de) | 2010-09-09 |
WO2008078167A2 (en) | 2008-07-03 |
EP2118136B1 (en) | 2010-07-28 |
EP2118136A2 (en) | 2009-11-18 |
DK2118136T3 (da) | 2010-11-15 |
JP2010513460A (ja) | 2010-04-30 |
WO2008078167A3 (en) | 2008-08-21 |
KR20150014999A (ko) | 2015-02-09 |
JP5253412B2 (ja) | 2013-07-31 |
PL2118136T3 (pl) | 2011-04-29 |
US8367602B2 (en) | 2013-02-05 |
CA2673382C (en) | 2016-03-29 |
KR20090117702A (ko) | 2009-11-12 |
AU2007337797A1 (en) | 2008-07-03 |
KR101493437B1 (ko) | 2015-02-16 |
AU2007337797B2 (en) | 2012-08-23 |
ES2349889T3 (es) | 2011-01-12 |
US20100172949A1 (en) | 2010-07-08 |
ATE475670T1 (de) | 2010-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY158325A (en) | Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection | |
TN2012000303A1 (en) | Oxyntomodulin peptide analogue | |
EP2528934A4 (en) | AROMATIC-CATIONIC PEPTIDES AND USES THEREOF | |
TN2012000302A1 (en) | Oxyntomodulin peptide analogue | |
IN2012DN03310A (xx) | ||
MX2009006466A (es) | Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina. | |
MX346450B (es) | Composiciones y métodos para el tratamiento de la enfermedad celíaca. | |
LT2506857T (lt) | Mrnr tiekimas baltymų ir fermentų papildymui žmogaus genetinių ligų atvejais | |
MX2019011592A (es) | Peptidos y analogos de peptidos protectores de los tejidos para evitar y tratar padecimientos y desordenes asociados con daño de los tejidos. | |
ZA200702322B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
MX2012009748A (es) | USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL. | |
UA94221C2 (xx) | Білок ліпокалін$белок липокалин | |
SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
MX2010005651A (es) | Inhibicion de receptor de proteina de estimulacion de macrofagos (ron) y sus metodos de tratamiento. | |
ZA200900379B (en) | Human endogenous retrovirus polypeptide compositions and methods of use thereof | |
MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
TN2012000511A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies | |
MX2012001346A (es) | Polipeptidos del factor ix modificados y usos de los mismos. | |
HK1127910A1 (en) | Compositions containing peptides with non-natural amino acids and methods of use | |
TN2009000135A1 (en) | Use of modified cyclosporins | |
HK1137186A1 (en) | Consensus peptide | |
EP2294197A4 (en) | HHIP1 PROTEIN VERSION AND METHOD AND USES THEREOF | |
WO2009132231A8 (en) | Peptidyl diacylglycerides | |
EP2229446A4 (en) | HYDROGENASE POLYPEPTIDE AND USE METHOD | |
MX2010005280A (es) | Nuevos peptidos sinteticos sustituidos con arginina y su uso. |